Botulinum A Toxin for Glabellar Wrinkles
- 1 November 1998
- journal article
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 24 (11) , 1181-1183
- https://doi.org/10.1111/j.1524-4725.1998.tb04095.x
Abstract
Botulinum A exotoxin injection is a well-established method for treatment of glabellar frown lines, crow's feet, and horizontal furrows of the forehead. However, there is no consensus as to the optimal dosage per injection site or the concentration of injectate to be used. The purpose of this study was to determine the minimal effective dose per injection site to be used as well as the effect of concentration in response to treatment. A total of 46 subjects were divided into ten groups and injected with escalating doses and concentrations of botulinum toxin. The response and longevity of treatment were then followed on a monthly basis. A dose between 2.5-4 U per injection site (12.5-20 U total) was determined to be an effective starting dose, with a duration of 2-5 months (median 14 weeks). There was no statistically significant difference in safety or efficacy for concentrations ranging from 50 to 200 U/ml of botulinum toxin.Keywords
This publication has 5 references indexed in Scilit:
- Contemporary Management of the Aging Brow and ForeheadThe Laryngoscope, 1997
- Botulinum toxin for correction of fronto-glabella wrinkles: Preliminary evaluationAesthetic Plastic Surgery, 1996
- Botulinum A exotoxin use in clinical dermatologyJournal of the American Academy of Dermatology, 1996
- Botulinum Toxin A for Hyperkinetic Facial Lines: Results of a Double-Blind, Placebo-Controlled StudyPlastic and Reconstructive Surgery, 1994
- Aesthetic Indications for Botulinum Toxin InjectionPlastic and Reconstructive Surgery, 1994